1. Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer
   RAFAŁ STEC et al, 2015, Oncology Letters CrossRef
2. Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta‐analysis
   Lauren C. Bylsma et al, 2020, Cancer Medicine CrossRef
3. KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer
   Yakup Ergun et al, 2019, Expert Review of Molecular Diagnostics CrossRef
4. Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer
   David M. Zocche et al, 2015, Frontiers in Genetics CrossRef